Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
about
Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, ChinaPatients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.HIV-Associated Tuberculosis.Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study.Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trialCurrent integration of tuberculosis (TB) and HIV services in South Africa, 2011.Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers.Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis.Tuberculosis in HIV programmes in lower-income countries: practices and risk factorsDebunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.Recent developments in the epidemiology and management of tuberculosis - new solutions to old problems?Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infectionCommunity-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?
P2860
Q27309915-FD61E710-F0EC-4D2C-AF2A-823CF5080FBAQ28365052-2075457C-A63B-4586-BCFA-0457FDD1A248Q33719226-4E55B97A-27F0-4C09-A510-67E5E7AA24D0Q34143510-B3D8EEB2-6A53-48E8-8482-1332DCE97D7EQ34257658-B5704A0B-004E-4779-88C3-5CD1CEFC1B53Q34515554-EE3CC2F4-EDA2-4C08-A5DA-D2801A221AC8Q34613299-D9F88099-555B-4AE5-808C-A6DB8ECEC927Q35023340-7F3FE2E1-E4E2-4EEB-889D-A5659AB6343CQ35072083-4D4ACD55-87D0-4D54-A6C2-EB95C60035DAQ35098753-CEF699F2-59F3-4705-95F5-64F84BE308CFQ35117177-43997087-AE27-487B-A555-50A63F971566Q35567798-DC6C0692-6377-42EC-A8D4-FED46860AC98Q35715390-9517C5BC-9AEF-438B-BBAA-95B702186C8BQ35748880-780DCA63-B2AA-4028-99DE-AA432D4C2FA1Q37021617-9426D730-F422-4336-99E6-B23B3DA3C270Q56669499-BA1BDE34-C676-470B-8235-3795B9D40BFE
P2860
Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Isoniazid preventive therapy f ...... ges and implementation issues.
@ast
Isoniazid preventive therapy f ...... ges and implementation issues.
@en
type
label
Isoniazid preventive therapy f ...... ges and implementation issues.
@ast
Isoniazid preventive therapy f ...... ges and implementation issues.
@en
prefLabel
Isoniazid preventive therapy f ...... ges and implementation issues.
@ast
Isoniazid preventive therapy f ...... ges and implementation issues.
@en
P2093
P1476
Isoniazid preventive therapy f ...... nges and implementation issues
@en
P2093
Aït-Khaled N
Caminero JA
Clevenbergh P
Enarson DA
P304
P577
2009-08-01T00:00:00Z